Data provider:

Icon data provider

A single online destination for seamlessly accessing and working with premium online journals, books, and databases from the world's leading publishers

Journal Article

Journal article

The inhibition of some cancers and the promotion of others by folic acid, vitamin B12, and their antagonists.  [1983]

Herbert V.; National Diabetes Information Clearinghouse (USA). National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases (USA). [Corporate Author]

Access the full text

A technical review suggests the hypothesis that folate or vitamin B12 deficiency (or any other cause of failure to methylate DNA and/or RNA) can activate malignancy by hypomethylation of oncogenes, and that the methylating oncogenes can inhibit malignancy by making them dormant. Specific attention is given to: the effects of folate deficiency; the role of vitamin B12; and studies on suppression testing to measure folate and vitamin B12 deficiencies in terms of slowing DNA synthesis.(wz).

From the journal

Bristol Myers nutrition symposia